<p>Biosig Technologies, Inc.（纳斯达克代码：STEX - 获取免费报告）首席信息官 Mitchell Young Williams 于 5 月 1 日星期五出售了 263,863 股该股票。股票的平均售价为 0.79 美元，总价值为 208,451.77 美元。交易后，该高管直接持有公司 3,037,648 股股票，估值约为 2,399,741.92 美元。此次交易使其持股比例减少了 7.99%。该出售在向美国证券交易委员会（SEC）提交的文件中披露，相关文件可通过此链接访问。此次出售是为了覆盖与股权奖励归属相关的税款扣缴义务。</p>
<p>获取 <strong>Biosig Technologies</strong> 的提醒：</p>
<h2>Biosig Technologies 股票表现</h2>
<p>纳斯达克 STEX 周一下跌 0.17 美元，达到 1.02 美元。该股票成交量为 1,588,220 股，而其平均成交量为 1,950,089 股。该股票的 50 日移动平均价格为 1.49 美元。公司市值为 1.8386 亿美元，市盈率为-0.11，贝塔值为 1.58。Biosig Technologies, Inc.的 12 个月低点为 0.70 美元，12 个月高点为 14.11 美元。</p>
<p>Biosig Technologies（纳斯达克：STEX - 获取免费报告）最近一次发布季度财报是在 3 月 31 日星期二。公司报告该季度每股收益为（8.23 美元）。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师最近对 STEX 股票发表了看法。Weiss Ratings 在周五的一份研究报告中将 Biosig Technologies 的评级从 “卖出（e+）” 上调至 “卖出（d-）”。Wall Street Zen 在 4 月 5 日星期日的一份研究报告中将 Biosig Technologies 的评级从 “持有” 下调至 “强烈卖出”。最后，Needham &amp; Company LLC 在 4 月 9 日星期四的一份研究报告中将 Biosig Technologies 的目标价格从 12.00 美元下调至 9.00 美元，并给予该公司 “买入” 评级。一个研究分析师对该股票给予了买入评级，另一个则对公司的股票给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 9.00 美元。</p>
<p><strong>查看我们对 STEX 的最新分析</strong></p>
<h2>Biosig Technologies 公司简介</h2>
<p>（获取免费报告）</p>
<p>Biosig Technologies 纳斯达克：STEX 是一家医疗技术公司，专注于开发用于心脏电生理学的先进信号采集和处理解决方案。该公司的工作重点是改善在电生理学程序中捕获的心内信号的清晰度和可解释性，旨在帮助临床医生识别引起心律失常的基质，并做出更明智的程序决策。</p>
<p>其主要产品是一个信号处理平台，结合了专有硬件和软件，以放大、过滤和显示心内电活动，减少噪声和失真。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票，而不是 Biosig Technologies</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RFWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RFWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Biosig Technologies 吗？</h2>
<p>在考虑 Biosig Technologies 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Biosig Technologies 并不在名单上。</p>
<p>虽然 Biosig Technologies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

STEX

<p>Biosig Technologies 首席信息官 Mitchell Young Williams 出售了 263,863 股，每股售价为 0.79 美元，总计 208,451.77 美元，持股比例减少了 7.99%。出售后，他持有 3,037,648 股，估值约为 240 万美元。此次出售是为了支付与股权奖励相关的税务义务。该股票最近交易价格下跌至 1.02 美元，市值为 1.8386 亿美元。分析师对该股票的评级不一，平均目标价为 9.00 美元，目前评级为持有</p>

<p>Biosig Technologies, Inc. (NASDAQ:STEX - Get Free Report) CIO Mitchell Young Williams sold 263,863 shares of the stock in a transaction on Friday, May 1st. The shares were sold at an average price of $0.79, for a total value of $208,451.77. Following the transaction, the executive directly owned 3,037,648 shares of the company's stock, valued at approximately $2,399,741.92. The trade was a 7.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.</p>
<div class="lb-trans"><p>Biosig Technologies, Inc.（纳斯达克代码：STEX - 获取免费报告）首席信息官 Mitchell Young Williams 于 5 月 1 日星期五出售了 263,863 股该股票。股票的平均售价为 0.79 美元，总价值为 208,451.77 美元。交易后，该高管直接持有公司 3,037,648 股股票，估值约为 2,399,741.92 美元。此次交易使其持股比例减少了 7.99%。该出售在向美国证券交易委员会（SEC）提交的文件中披露，相关文件可通过此链接访问。此次出售是为了覆盖与股权奖励归属相关的税款扣缴义务。</p>
</div><p>Get <strong>Biosig Technologies</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Biosig Technologies</strong> 的提醒：</p>
</div><h2>Biosig Technologies Stock Performance</h2>
<div class="lb-trans"><h2>Biosig Technologies 股票表现</h2>
</div><p>NASDAQ STEX traded down $0.17 on Monday, reaching $1.02. 1,588,220 shares of the stock traded hands, compared to its average volume of 1,950,089. The stock's fifty day moving average price is $1.49. The company has a market capitalization of $183.86 million, a P/E ratio of -0.11 and a beta of 1.58. Biosig Technologies, Inc. has a 12 month low of $0.70 and a 12 month high of $14.11.</p>
<div class="lb-trans"><p>纳斯达克 STEX 周一下跌 0.17 美元，达到 1.02 美元。该股票成交量为 1,588,220 股，而其平均成交量为 1,950,089 股。该股票的 50 日移动平均价格为 1.49 美元。公司市值为 1.8386 亿美元，市盈率为-0.11，贝塔值为 1.58。Biosig Technologies, Inc.的 12 个月低点为 0.70 美元，12 个月高点为 14.11 美元。</p>
</div><p>Biosig Technologies (NASDAQ:STEX - Get Free Report) last released its quarterly earnings data on Tuesday, March 31st. The company reported ($8.23) earnings per share for the quarter.</p>
<div class="lb-trans"><p>Biosig Technologies（纳斯达克：STEX - 获取免费报告）最近一次发布季度财报是在 3 月 31 日星期二。公司报告该季度每股收益为（8.23 美元）。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts have recently weighed in on STEX shares. Weiss Ratings raised Biosig Technologies from a &#34;sell (e+)&#34; rating to a &#34;sell (d-)&#34; rating in a research note on Friday. Wall Street Zen lowered Biosig Technologies from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a research note on Sunday, April 5th. Finally, Needham &amp; Company LLC reduced their price objective on Biosig Technologies from $12.00 to $9.00 and set a &#34;buy&#34; rating for the company in a research note on Thursday, April 9th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and an average target price of $9.00.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 STEX 股票发表了看法。Weiss Ratings 在周五的一份研究报告中将 Biosig Technologies 的评级从 “卖出（e+）” 上调至 “卖出（d-）”。Wall Street Zen 在 4 月 5 日星期日的一份研究报告中将 Biosig Technologies 的评级从 “持有” 下调至 “强烈卖出”。最后，Needham &amp; Company LLC 在 4 月 9 日星期四的一份研究报告中将 Biosig Technologies 的目标价格从 12.00 美元下调至 9.00 美元，并给予该公司 “买入” 评级。一个研究分析师对该股票给予了买入评级，另一个则对公司的股票给予了卖出评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “持有”，平均目标价格为 9.00 美元。</p>
</div><p><strong>View Our Latest Analysis on STEX</strong></p>
<div class="lb-trans"><p><strong>查看我们对 STEX 的最新分析</strong></p>
</div><h2>Biosig Technologies Company Profile</h2>
<div class="lb-trans"><h2>Biosig Technologies 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Biosig Technologies NASDAQ: STEX is a medical technology company focused on developing advanced signal acquisition and processing solutions for cardiac electrophysiology. The company’s work centers on improving the clarity and interpretability of intracardiac signals captured during electrophysiology procedures, with the goal of helping clinicians identify arrhythmogenic substrates and make more informed procedural decisions.</p>
<div class="lb-trans"><p>Biosig Technologies 纳斯达克：STEX 是一家医疗技术公司，专注于开发用于心脏电生理学的先进信号采集和处理解决方案。该公司的工作重点是改善在电生理学程序中捕获的心内信号的清晰度和可解释性，旨在帮助临床医生识别引起心律失常的基质，并做出更明智的程序决策。</p>
</div><p>Its primary offering is a signal-processing platform that combines proprietary hardware and software to amplify, filter and display intracardiac electrical activity with reduced noise and distortion.</p>
<div class="lb-trans"><p>其主要产品是一个信号处理平台，结合了专有硬件和软件，以放大、过滤和显示心内电活动，减少噪声和失真。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Biosig Technologies</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Biosig Technologies</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9U1RFWA" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NASDAQ&amp;Symbol=STEX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Biosig Technologies Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Biosig Technologies 吗？</h2>
</div><p>Before you consider Biosig Technologies, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Biosig Technologies 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Biosig Technologies wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Biosig Technologies 并不在名单上。</p>
</div><p>While Biosig Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Biosig Technologies 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Biosig Technologies（纳斯达克代码：STEX）的首席信息官 Mitchell Young Williams 出售了 263,863 股股票